Secondary endpoints included basal and citric acid primed whole salivary production ( WSP ) , ratios of positive responders ( defined as patients with 20 % reduction in overall radiation-induced xerostomia symptom burden ) , and the presence of adverse events based on the Common Terminology Criteria for Adverse Events version 3 .